Course and treatment characteristics of “obstetric” atypical hemolytic-uremic syndrome (aHUS)
Abstract
About the Authors
Y. V. KorotchaevaRussian Federation
N. L. Kozlovskaya
Russian Federation
T. V. Bondarenko
Russian Federation
G. A. Veselov
Russian Federation
References
1. Tsai H.M. A Mechanistic Approach to the Diagnosis and Management of Atypical Hemolytic Uremic Syndrome. Transfus Med Rev 2014; Oct; 28(4): 187-197.
2. Fakhouri F., Fremeaux-Bacchi V. Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura. Nat Clin Pract Nephrol 2007; 3: 679-687.
3. Noris M., Giuseppe R. Atypical hemolytic-uremic syndrome. N Engl J Med 2009; 361: 1676-1687.
4. Fakhouri F1., Vercel C., Frémeaux-Bacchi V. Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy. Clin J Am Soc Nephrol. 2012 Dec; 7(12): 2100-2106.
5. Meri S. Complement activation in diseases presenting with thrombotic microangiopathy. Eur J Intern Med 2013 Sep; 24(6): 496-502.
6. McMinn J.R., George J.N. Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome during pregnancy. J Clin l Apheresis 2001; 16: 202-209.
7. Owens M.Y., Martin J.N.Jr., Wallace K. et al. Postpartum thrombotic microangiopathic syndrome. Transfus Apher Sci 2013 Feb; 48(1): 51-57
8. Han-Mou Tsai. Untying the Knot of Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome. 2013; 126 (3): 200-209
9. Козловская Н.Л., Меркушева Л.И., КирсановаТ.В. и др. Особенности течения и исхода атипичного гемолитико-уремического синдрома при беременности. Клиническая Нефрология 2012; 3: 44-49 [Kozlovskaia N.L., Merkusheva L.I., KirsanovaT.V. i dr. Osobennosti techeniia i is-hoda atipichnogo gemolitiko-uremicheskogo sindroma pri beremennosti. Cli-nicheskaia Nefrologiia 2012; 3: 44-49]
10. Noris M., Caprioli J., Bresin E. et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am SocNephrol 2010; 5: 1844-1859
11. Noris M1., Remuzzi G. Thrombotic microangiopathy after kidney transplantation. Am J Transplant2010 Jul; 10(7): 1517-1523
12. Ganesan C., Maynard S.E. Acute kidney injury in pregnancy: the thrombotic microangiopathies. J Nephrol 2011; 24: 554-563
13. Fakhouri F., Roumenina L., Provot F. et al. Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations. J Am Soc Nephrol 2010; 21: 859-867.
14. Sanches-Luseros A., Farias С. Von Willebrand factor-cleaving protease (ADAMTS-13) activity in normal non-pregnant women, pregnant and postdelivery women. Thromb. Haemost 2004; 92: 1320-1326.
15. Amara U., Rittrisch D., Flierl M. et al. Interaction between the coagulation and complement system. Adv Exp Med Biol 2008; 632: 71-79
16. Козловская Н.Л. Антикоагулянты в практике нефролога. Клиническая нефрология 2011; 1: 15-22 [Kozlovskaia N.L. Antikoagulianty' v praktike nefrologa. Clinicheskaia nefrolo-giia 2011; 1: 15-22]
17. Loirat C., Garnier A., Sellier-Leclerc A.L. et al. Plasmatherapy in atypical hemolytic uremic syndrome. Semin Thromb Hemost 2010; 36: 673-681
Review
For citations:
Korotchaeva Y.V., Kozlovskaya N.L., Bondarenko T.V., Veselov G.A. Course and treatment characteristics of “obstetric” atypical hemolytic-uremic syndrome (aHUS). Nephrology (Saint-Petersburg). 2015;19(2):76-81. (In Russ.)